Are Plasma Thyroid-Stimulating Hormone Levels Associated with Degree of Obesity and Metabolic Syndrome in Euthyroid Obese Patients? A Turkish Cohort Study

Table 2

Demographic data of all patients, subgroups, and control group. The data were reported as mean ± StdDev.

Characteristics	All patients	Group 1	Group 2	Group 3	Group 4	Group 5	Controls
Number of patients (𝑛)	629	133	330	166	102	527	150
Age (years)	37.13±11.18	34.04±9.83	36.68±10.55	40.92±12.3	36.06±10.9	37.33±11.2	36.67±10.33
Weight (kg)	94.99±20.16	74.73±7.50	92.44±12.32	117.28±17.57	114.21±23.13	91.27±17.23	67±12.41
Waist circumference (cm)	108.87±14.65	96.86±7	106.78±10.18	123.52±14.25	121.27±16.81	106.47±12.89	87±8.42
BMI (kg/m^2)	36.01±7.15	27.92±1.3	34.73±2.79	45.48±4.81	37.45±6.95	35.74±7.16	23.18±1.49
TANITA body-fat percentage (%)	41.24±8.12	35.01±4.57	40.72±5.92	47.10±5.88	35.13±7.72	42.42±7.66	24.89±7.43
TSH (mIU/mL)	1.83±0.94	1.63±0.77	1.84±0.94	1.94±1.02	1.71±0.77	1.85±0.97	1.69±0.89
Patients with metabolic syndrome (𝑛)	330	35	179	116	58	272	0
Patients with hypertension (𝑛)	119	5	51	63	24	95	0
Fasting plasma glucose (mg/dL)	97.36±13.65	93.16±7.7	97.12±12.92	101.74±17.12	100.85±15.32	96.68±13.21	89±6.9
Triglyceride (mg/dL)	145.46±83.47	124.18±78.04	147.68±80.32	163.71±90.02	183.68±101.11	138.06±77.58	121.12±42.87
HDL cholesterol (mg/dL)	45.93±12.04	49.33±11.48	45.49±11.47	42.86±11.3	39.62±11.1	47.16±11.84	50.02±14.21